PCSK9 inhibitors, which increase LDL clearance, have just been approved to treat certain types of hyperlipidemia [15] but their use is not yet sufficiently prevalent to examine their effect on increased LDL clearance in sepsis. The gene discussed is PCSK9; the disease is Sepsis.